
APUS Technical Analysis Summary (AMEX)
Analyze APUS on the AMEX with RSI, MACD, ADX, Bollinger Bands, support, resistance, momentum, and the latest technical trading signals.
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerAPUS Technical Analysis Summary (AMEX)
Apimeds Pharmaceuticals US, Inc (AMEX: APUS) stock currently shows a bearish trend on the AMEX, supported by momentum and weak buying pressure.
Technical conditions suggest Apimeds Pharmaceuticals US, Inc on the AMEX is awaiting a decisive move. Technical signals suggest downside risk is building despite recent strength.
RSI (14): 38.97
Stochastic %K: 18.30
Williams %R: -64.31
Rate of Change (ROC): -17.89
Takeaway:Apimeds Pharmaceuticals US, Inc shows weakening momentum, with sellers gaining the edge.
MACD: -0.13
ADX: 27.17
ATR (14): 0.14
CCI (14): 14.60
Takeaway:Apimeds Pharmaceuticals US, Inc shows weakening trend signals, with bearish pressure building.
Takeaway:Apimeds Pharmaceuticals US, Inc trades near the upper band, signaling overbought conditions and risk of pullback.
Takeaway:Apimeds Pharmaceuticals US, Inc trades near the upper channel, signaling resistance and risk of pullback.
Overall Takeaway:APUS shows mixed signals in money flow analysis.
Bullish Signals
ADX above 20 → strong underlying trend.
Price trading above middle Bollinger Band → mid-term support intact.
MFI below 80 → room for more buying without overbought risk.
Bearish Signals
Price near upper Bollinger Band → potential resistance and pullback risk.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Apimeds Pharmaceuticals US, Inc shows a Bearish signal — selling pressure is building, with trend indicators favoring downside.